Thomas Advanced Medical

CompanyUnited States

Thomas Advanced Medical develops one asset, in phase 1 (PrimePro/ PrimeMSK in autoimmune disease). Mostly cell therapy; based in the United States.

1
Asset
Furthest stage: Phase 1; 1
Trial: 2
Signals

Pipeline

1

PrimePro/ PrimeMSK
Mesenchymal stem cell therapy to promote tissue regeneration and repair acute and chronic conditions
Phase 1, Cell therapy, autoimmune disease, cardiovascular disease

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials1
Signals2
Similar companies6